Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation.

Huck C, Leppert D, Wegert V, Schmid C, Dunn R, Weckbecker G, Smith PA.

J Neuroimmune Pharmacol. 2019 Aug 21. doi: 10.1007/s11481-019-09872-z. [Epub ahead of print]

PMID:
31435856
2.

Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.

Theil D, Smith P, Huck C, Gilbart Y, Kakarieka A, Leppert D, Rauld C, Schmid C, Baumgartner R, Stuber N, Cordoba F, Dubost V, Darribat K, Jivkov M, Frieauff W, Kneuer R, Stoeckli M, Reinker S, Mansfield K, Carballido JM, Couttet P, Weckbecker G.

Front Immunol. 2019 Jun 20;10:1340. doi: 10.3389/fimmu.2019.01340. eCollection 2019.

3.

Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.

Schröder C, Azimzadeh AM, Wu G, Price JO, Atkinson JB, Pierson RN.

Transpl Immunol. 2003 Oct-Nov;12(1):19-28.

PMID:
14551029
4.

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.

Häusler D, Häusser-Kinzel S, Feldmann L, Torke S, Lepennetier G, Bernard CCA, Zamvil SS, Brück W, Lehmann-Horn K, Weber MS.

Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9773-9778. doi: 10.1073/pnas.1810470115. Epub 2018 Sep 7.

6.
7.

Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.

Alwayn IP, Xu Y, Basker M, Wu C, Buhler L, Lambrigts D, Treter S, Harper D, Kitamura H, Vitetta ES, Abraham S, Awwad M, White-Scharf ME, Sachs DH, Thall A, Cooper DK.

Xenotransplantation. 2001 Aug;8(3):157-71.

PMID:
11472623
9.

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF.

J Immunol. 2005 Apr 1;174(7):4389-99.

10.

B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, Tisch RM, Tedder TF.

J Immunol. 2008 Mar 1;180(5):2863-75.

11.

Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeys.

Mao CP, Brovarney MR, Dabbagh K, Birnböck HF, Richter WF, Del Nagro CJ.

PLoS One. 2013 Nov 12;8(11):e80533. doi: 10.1371/journal.pone.0080533. eCollection 2013.

12.

Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.

Gadri Z, Kukulansky T, Bar-Or E, Haimovich J, Hollander N.

J Immunother. 2009 May;32(4):333-40. doi: 10.1097/CJI.0b013e31819b7c17.

PMID:
19342972
13.
15.

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma.

Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R.

Blood. 1994 Oct 15;84(8):2457-66.

PMID:
7522629
16.
17.

Characterization of the adaptive immune response following immunization in pregnant sows (Sus scrofa) kept in two different housing systems.

Grün V, Schmucker S, Schalk C, Flauger B, Stefanski V.

J Anim Sci. 2014 Aug;92(8):3388-97. doi: 10.2527/jas.2013-7531. Epub 2014 Jun 19.

PMID:
24948651
19.

B cell memory to thymus-independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction.

Zhang J, Liu YJ, MacLennan IC, Gray D, Lane PJ.

Eur J Immunol. 1988 Sep;18(9):1417-24.

PMID:
2458943

Supplemental Content

Support Center